Yi Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yi Li has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Yamei Tang
Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
3 shared publications Baixuan He
Department of Neurology (Y. Xiao, X.Z., H.S., Y. Xu, B.H., Y.C., H.H., X.C., W.Y., M.B., Y.P., Y.L., S.X., X.Y., Y.T.), Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
2 shared publications- Wei-Jye Lin
Brain Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
2 shared publications - Yongteng Xu
Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
2 shared publications - Zhongshan Shi
Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
2 shared publications - Charles B. Simone
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
1 shared publication
Latest Publications
- 27 February 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1019, 178703
Association of gastric-acid suppressants with sedatives and analgesics in intensive care patients: A retrospective cohort study
- 27 February 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1019, 178703
Association of gastric-acid suppressants with sedatives and analgesics in intensive care patients: A retrospective cohort study
- 1 November 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (11) , 3187-3198
Effectiveness of Endovascular Treatment for Acute Mild Basilar Artery Occlusion Stroke: A Multicenter Real-World Study
BACKGROUND: Randomized trials have demonstrated the benefit of endovascular treatment (EVT) in moderate-to-severe acute basilar artery occlusion (BAO), but its benefit in acute mild BAO remains uncertain. This multicenter, retrospective cohort study aimed to explore the efficacy of EVT in acute BAO with a low National Institutes of Health Stroke Scale. METHODS: Patients with acute BAO and National Institutes of Health Stroke Scale P P =0.80). However, EVT was associated with a higher risk of symptomatic intracerebral hemorrhage (8.2% versus 3.9%; adjusted odds ratio, 3.86 [95% CI, 1.18–12.61]; P =0.03). CONCLUSIONS: In this cohort of patients with acute mild BAO, EVT was associated with an improved 90-day functional outcome compared with standard medical treatment alone, although the risk of symptomatic intracerebral hemorrhage was increased.
- 1 November 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (11) , 3187-3198
Effectiveness of Endovascular Treatment for Acute Mild Basilar Artery Occlusion Stroke: A Multicenter Real-World Study
BACKGROUND: Randomized trials have demonstrated the benefit of endovascular treatment (EVT) in moderate-to-severe acute basilar artery occlusion (BAO), but its benefit in acute mild BAO remains uncertain. This multicenter, retrospective cohort study aimed to explore the efficacy of EVT in acute BAO with a low National Institutes of Health Stroke Scale. METHODS: Patients with acute BAO and National Institutes of Health Stroke Scale P P =0.80). However, EVT was associated with a higher risk of symptomatic intracerebral hemorrhage (8.2% versus 3.9%; adjusted odds ratio, 3.86 [95% CI, 1.18–12.61]; P =0.03). CONCLUSIONS: In this cohort of patients with acute mild BAO, EVT was associated with an improved 90-day functional outcome compared with standard medical treatment alone, although the risk of symptomatic intracerebral hemorrhage was increased.
- 25 April 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 72 (10) , 3120-3132
Deep Learning-Augmented Sleep Spindle Detection for Acute Disorders of Consciousness: Integrating CNN and Decision Tree Validation
Sleep spindles, which are key biomarkers of non-rapid eye movement stage 2 sleep, play a crucial role in predicting outcomes for patients with acute disorders of consciousness (ADOC). However, several critical challenges remain in spindle detection: 1) the limited use of automated spindle detection in ADOC; 2) the difficulty in identifying low-frequency spindles in patient populations; and 3) the lack of effective tools for quantitatively analyzing the relationship between spindle density and patient outcomes. To address these challenges, we propose a novel Deep Learning-Augmented algorithm for automated sleep spindle detection in ADOC patients. This method combines Convolutional Neural Networks with decision tree-assisted validation, using wavelet transform principles to enhance detection accuracy and sensitivity, especially for the slow spindles commonly found in ADOC patients. Our approach not only demonstrates superior performance and reliability but also has the potential to significantly improve diagnostic precision and guide treatment strategies when integrated into clinical practice. Our algorithm was evaluated on the Montreal Archive of Sleep Studies - Session 2 (MASS SS2, n = 19), achieving average F1 scores of 0.798 and 0.841 compared to annotations from two experts. On a self-recorded dataset from ADOC patients (n = 24), it achieved an F1 score of 0.745 compared to expert annotations. Additionally, our analysis using the Spearman correlation coefficient revealed a moderate positive correlation between sleep spindle density and 28-day Glasgow Outcome Scale scores in ADOC patients. This suggests that spindle density could serve as a prognostic marker for predicting clinical outcomes and guiding personalized patient care.
- 25 April 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 72 (10) , 3120-3132
Deep Learning-Augmented Sleep Spindle Detection for Acute Disorders of Consciousness: Integrating CNN and Decision Tree Validation
Sleep spindles, which are key biomarkers of non-rapid eye movement stage 2 sleep, play a crucial role in predicting outcomes for patients with acute disorders of consciousness (ADOC). However, several critical challenges remain in spindle detection: 1) the limited use of automated spindle detection in ADOC; 2) the difficulty in identifying low-frequency spindles in patient populations; and 3) the lack of effective tools for quantitatively analyzing the relationship between spindle density and patient outcomes. To address these challenges, we propose a novel Deep Learning-Augmented algorithm for automated sleep spindle detection in ADOC patients. This method combines Convolutional Neural Networks with decision tree-assisted validation, using wavelet transform principles to enhance detection accuracy and sensitivity, especially for the slow spindles commonly found in ADOC patients. Our approach not only demonstrates superior performance and reliability but also has the potential to significantly improve diagnostic precision and guide treatment strategies when integrated into clinical practice. Our algorithm was evaluated on the Montreal Archive of Sleep Studies - Session 2 (MASS SS2, n = 19), achieving average F1 scores of 0.798 and 0.841 compared to annotations from two experts. On a self-recorded dataset from ADOC patients (n = 24), it achieved an F1 score of 0.745 compared to expert annotations. Additionally, our analysis using the Spearman correlation coefficient revealed a moderate positive correlation between sleep spindle density and 28-day Glasgow Outcome Scale scores in ADOC patients. This suggests that spindle density could serve as a prognostic marker for predicting clinical outcomes and guiding personalized patient care.
- 22 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (684) , eabm6543
A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury
Radiation-induced brain injury (RIBI) is a debilitating sequela after radiotherapy to treat head and neck cancer, and 20 to 30% of patients with RIBI fail to respond to or have contraindications to the first-line treatments of bevacizumab and corticosteroids. Here, we reported a Simon’s minmax two-stage, single-arm, phase 2 clinical trial (NCT03208413) to assess the efficacy of thalidomide in patients with RIBI who were unresponsive to or had contraindications to bevacizumab and corticosteroid therapies. The trial met its primary endpoint, with 27 of 58 patients enrolled showing ≥25% reduction in the volume of cerebral edema on fluid-attenuated inversion recovery–magnetic resonance imaging (FLAIR-MRI) after treatment (overall response rate, 46.6%; 95% CI, 33.3 to 60.1%). Twenty-five (43.1%) patients demonstrated a clinical improvement based on the Late Effects Normal Tissues–Subjective, Objective, Management, Analytic (LENT/SOMA) scale, and 36 (62.1%) experienced cognitive improvement based on the Montreal Cognitive Assessment (MoCA) scores. In a mouse model of RIBI, thalidomide restored the blood-brain barrier and cerebral perfusion, which were attributed to the functional rescue of pericytes secondary to elevation of platelet-derived growth factor receptor β (PDGFRβ) expression by thalidomide. Our data thus demonstrate the therapeutic potential of thalidomide for the treatment of radiation-induced cerebral vasculature impairment.
- 22 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (684) , eabm6543
A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury
Radiation-induced brain injury (RIBI) is a debilitating sequela after radiotherapy to treat head and neck cancer, and 20 to 30% of patients with RIBI fail to respond to or have contraindications to the first-line treatments of bevacizumab and corticosteroids. Here, we reported a Simon’s minmax two-stage, single-arm, phase 2 clinical trial (NCT03208413) to assess the efficacy of thalidomide in patients with RIBI who were unresponsive to or had contraindications to bevacizumab and corticosteroid therapies. The trial met its primary endpoint, with 27 of 58 patients enrolled showing ≥25% reduction in the volume of cerebral edema on fluid-attenuated inversion recovery–magnetic resonance imaging (FLAIR-MRI) after treatment (overall response rate, 46.6%; 95% CI, 33.3 to 60.1%). Twenty-five (43.1%) patients demonstrated a clinical improvement based on the Late Effects Normal Tissues–Subjective, Objective, Management, Analytic (LENT/SOMA) scale, and 36 (62.1%) experienced cognitive improvement based on the Montreal Cognitive Assessment (MoCA) scores. In a mouse model of RIBI, thalidomide restored the blood-brain barrier and cerebral perfusion, which were attributed to the functional rescue of pericytes secondary to elevation of platelet-derived growth factor receptor β (PDGFRβ) expression by thalidomide. Our data thus demonstrate the therapeutic potential of thalidomide for the treatment of radiation-induced cerebral vasculature impairment.
- 18 April 2022
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (2) , 893-905
Partial Ablation of Astrocytes Exacerbates Cerebral Infiltration of Monocytes and Neuronal Loss After Brain Stab Injury in Mice
In traumatic brain injury (TBI), mechanical injury results in instantaneous tissue damages accompanied by subsequent pro-inflammatory cascades composed of microgliosis and astrogliosis. However, the interactive roles between microglia and astrocytes during the pathogenesis of TBI remain unclear and sometimes debatable. In this study, we used a forebrain stab injury mouse model to investigate the pathological role of reactive astrocytes in cellular and molecular changes of inflammatory response following TBI. In the ipsilateral hemisphere of stab-injured brain, monocyte infiltration and neuronal loss, as well as increased elevated astrogliosis, microglia activation and inflammatory cytokines were observed. To verify the role of reactive astrocytes in TBI, local and partial ablation of astrocytes was achieved by stereotactic injection of diphtheria toxin in the forebrain of Aldh1l1-CreERT2::Ai9::iDTR transgenic mice which expressed diphtheria toxin receptor (DTR) in astrocytes after tamoxifen induction. This strategy achieved about 20% of astrocytes reduction at the stab site as validated by immunofluorescence co-staining of GFAP with tdTomato-positive astrocytes. Interestingly, reduction of astrocytes showed increased microglia activation and monocyte infiltration, accompanied with increased severity in stab injury-induced neuronal loss when compared with DTR−/− mice, together with elevation of inflammatory chemokines such as CCL2, CCL5 and CXCL10 in astrogliosis-reduced mice. Collectively, our data verified the interactive role of astrocytes as an immune modulator in suppressing inflammatory responses in the injured brain. Graphical Abstract Schematic diagram shows monocyte infiltration and neuronal loss, as well as increased elevated astrogliosis, microglia activation and chemokines were observed in the injured site after stab injury. Local and partial ablation of astrocytes led to increased microglia activation and monocyte infiltration, accompanied with increased severity in neuronal loss together with elevation of inflammatory chemokines as compared with control mice subjected stab injury.
- 18 April 2022
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (2) , 893-905
Partial Ablation of Astrocytes Exacerbates Cerebral Infiltration of Monocytes and Neuronal Loss After Brain Stab Injury in Mice
In traumatic brain injury (TBI), mechanical injury results in instantaneous tissue damages accompanied by subsequent pro-inflammatory cascades composed of microgliosis and astrogliosis. However, the interactive roles between microglia and astrocytes during the pathogenesis of TBI remain unclear and sometimes debatable. In this study, we used a forebrain stab injury mouse model to investigate the pathological role of reactive astrocytes in cellular and molecular changes of inflammatory response following TBI. In the ipsilateral hemisphere of stab-injured brain, monocyte infiltration and neuronal loss, as well as increased elevated astrogliosis, microglia activation and inflammatory cytokines were observed. To verify the role of reactive astrocytes in TBI, local and partial ablation of astrocytes was achieved by stereotactic injection of diphtheria toxin in the forebrain of Aldh1l1-CreERT2::Ai9::iDTR transgenic mice which expressed diphtheria toxin receptor (DTR) in astrocytes after tamoxifen induction. This strategy achieved about 20% of astrocytes reduction at the stab site as validated by immunofluorescence co-staining of GFAP with tdTomato-positive astrocytes. Interestingly, reduction of astrocytes showed increased microglia activation and monocyte infiltration, accompanied with increased severity in stab injury-induced neuronal loss when compared with DTR−/− mice, together with elevation of inflammatory chemokines such as CCL2, CCL5 and CXCL10 in astrogliosis-reduced mice. Collectively, our data verified the interactive role of astrocytes as an immune modulator in suppressing inflammatory responses in the injured brain. Graphical Abstract Schematic diagram shows monocyte infiltration and neuronal loss, as well as increased elevated astrogliosis, microglia activation and chemokines were observed in the injured site after stab injury. Local and partial ablation of astrocytes led to increased microglia activation and monocyte infiltration, accompanied with increased severity in neuronal loss together with elevation of inflammatory chemokines as compared with control mice subjected stab injury.